- Home
- CAPR vs FTEL Comparison
CAPR vs FTEL Comparison
Compare CAPR & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- FTEL
- Stock Information
- Founded
- CAPR 2005
- FTEL 2007
- Country
- CAPR United States
- FTEL Australia
- Employees
- CAPR N/A
- FTEL N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- FTEL
- Sector
- CAPR Health Care
- FTEL
- Exchange
- CAPR Nasdaq
- FTEL Nasdaq
- Market Cap
- CAPR 332.5M
- FTEL 317.4M
- IPO Year
- CAPR N/A
- FTEL 2023
- Fundamental
- Price
- CAPR $19.65
- FTEL $31.83
- Analyst Decision
- CAPR Strong Buy
- FTEL
- Analyst Count
- CAPR 6
- FTEL 0
- Target Price
- CAPR $35.50
- FTEL N/A
- AVG Volume (30 Days)
- CAPR 1.9M
- FTEL 126.0K
- Earning Date
- CAPR 11-13-2024
- FTEL 11-25-2024
- Dividend Yield
- CAPR N/A
- FTEL N/A
- EPS Growth
- CAPR N/A
- FTEL N/A
- EPS
- CAPR N/A
- FTEL N/A
- Revenue
- CAPR $27,152,218.00
- FTEL $3,868,189.00
- Revenue This Year
- CAPR N/A
- FTEL N/A
- Revenue Next Year
- CAPR $135.53
- FTEL N/A
- P/E Ratio
- CAPR N/A
- FTEL N/A
- Revenue Growth
- CAPR 187.15
- FTEL N/A
- 52 Week Low
- CAPR $2.68
- FTEL $0.88
- 52 Week High
- CAPR $23.40
- FTEL $39.89
- Technical
- Relative Strength Index (RSI)
- CAPR 53.80
- FTEL 58.13
- Support Level
- CAPR $17.50
- FTEL $25.04
- Resistance Level
- CAPR $20.37
- FTEL $34.83
- Average True Range (ATR)
- CAPR 1.57
- FTEL 4.74
- MACD
- CAPR -0.73
- FTEL -0.12
- Stochastic Oscillator
- CAPR 24.91
- FTEL 52.65
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains.